Publix Athletic Foot

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Publix Athletic Foot
Generic name: CLOTRIMAZOLE 1%
Manufacturer: PUBLIX SUPER MARKETS, INC.
Product type: HUMAN OTC DRUG
SPL set ID: d9f99680-5636-4136-a7c6-c3643339e6b4
SPL ID: 78c33045-bd41-489a-98ec-9afd8461bbea
Version: 2
Effective date: 2024-08-02
Source export date: 2026-11-06
Source partition: 3
Source file: https://download.open.fda.gov/drug/label/drug-label-0003-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-11-06/97001096994db9ca8cee114e6c3bb5298d3c573158ffc1ab8692d82e76a3eb40/drug-label-0003-of-0014.json.zip
Source manifest SHA-256: 4a7570ba105b5a039a8e1c94a85e7f085b9047a8882a35a96bf1e4516c5ffc97
Import run: 20261108T063105Z
Imported at: 2026-11-08 06:56:59

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M005	openfda.application_number
brand name		Publix Athletic Foot	openfda.brand_name
generic name		CLOTRIMAZOLE 1%	openfda.generic_name
manufacturer name		PUBLIX SUPER MARKETS, INC.	openfda.manufacturer_name
ndc	package	56062-817-28	openfda.package_ndc
ndc	product	56062-817	openfda.product_ndc
ndc11	package	56062081728	derived:openfda.package_ndc
rxcui		309367	openfda.rxcui
spl id		78c33045-bd41-489a-98ec-9afd8461bbea	id
spl set id		d9f99680-5636-4136-a7c6-c3643339e6b4	set_id
unii		G07GZ97H65	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only Do not use on children under 2 years of age unless directed by a doctor. When using this product avoid contact with eyes. Stop use and consult a doctor if irritation occurs if there is not improvement within 2 weeks

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.